Wedbush Upgrades Stericycle (SRCL) to Outperform as Growth Prospects Justify Premium Valuation
Tweet Send to a Friend
Wedbush upgraded Stericycle (NASDAQ: SRCL) to Outperform. PT increased from $74 to $94.
Wedbush analyst says, "Our upgrade is predicated ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "Our upgrade is predicated ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
